Company Biography
Origin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on developing and commercializing a treatment for Molybdenum Cofactor Deficiency (MoCD) Type A. Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment for MoCD Type A to market as quickly as possible.
Contact Information
Name
Quinn Nazarewycz
Address
75 Park Plaza
Second Floor
Boston, MA 02116
Second Floor
Boston, MA 02116
You have chosen to your
information with
Origin Biosciences, Inc.
Team Members
Nils Confer
Origin Biosciences, Inc
VP, Medical Affairs
Mary Hames
Origin Biosciences, Inc
Regional Medical Director – Central
Megan Madden
Origin Biosciences, Inc
Regional Medical Director – West